Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AHG
STRONG SELLGet insider-trade alertsAkso Health Group · Healthcare · China · $1.3B · Avg Vol: $18K/d
COMPANY DESCRIPTION
Akso Health Group is a Chinese healthcare company primarily engaged in the distribution of medical devices, equipment, and consumables to hospitals and other healthcare institutions. The company also offers integrated solutions and services to its clients. Its competitive strength derives from its established distribution network, strong relationships with manufacturers and healthcare providers, and a comprehensive product portfolio within the Chinese market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 6.0M | 13.2M | 2.4M | 14.8M | 35.0% | 14.8M |
| EPS | -0.07 | -0.00 | -0.21 | -0.48 | — | -0.48 |
| Shares | 854.0M | 854.0M | 438.3M | 1.6B | +93.1% | — |
| Debt | 50.5M | 11.6M | 0 | 81,737 | -88.3% | 2.1M |
| Equity | 12.3M | 8.7M | 138.4M | 199.1M | 153.1% | — |
| Op CF | -8.6M | -3.3M | 1.4M | 1.2M | -12.9% | 7.3M |
| Inv CF | -20.0M | 18.5M | -54.7M | -105.9M | — | — |
| Fin CF | 34.8M | -27.5M | 131.7M | 195.9M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AHG are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AHG | Akso Health Group(you) | $1.3B | 12 | STRONG SELL |
| 301584.SZ | Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. | $1.2B | 29 | SELL |
| 2656.HK | 160 Health International Limited | $419M | 5 | STRONG SELL |
| 000950.SZ | C.Q. Pharmaceutical Holding Co., Ltd. | $1.3B | 51 | HOLD |
| 002589.SZ | Realcan Pharmaceutical Group Co., Ltd. | $543M | 39 | HOLD |
| 1931.HK | ETHK Labs Inc. | $125M | 14 | STRONG SELL |
| 0314.HK | Sipai Health Technology Co., Ltd. | $119M | 18 | STRONG SELL |
| 600739.SS | Liaoning Cheng Da Co., Ltd. | $2.2B | 56 | HOLD |
| 600056.SS | China Meheco Group Co., Ltd. | $1.9B | 80 | BUY |
| 301015.SZ | Qingdao Baheal Medical INC. | $1.5B | 86 | STRONG BUY |
Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%